1. Introduction {#sec1-medicines-04-00017}
===============

*Ocimum forskolei* Benth. (Lamiaceae) is one of about 65 tropical and subtropical species of *Ocimum*, seven of which are found in Yemen, and these include *O. basilicum* L., *O. tenuiflorum* L., *O. suave* Willd., *O. spicatum* Deflers, *O. gratissimum* L., and *O. forskolei* \[[@B1-medicines-04-00017]\]. Several species of *Ocimum* are aromatic and used as flavoring agents, insect repellents, and traditional medicines \[[@B2-medicines-04-00017]\]. *O. forskolei* ranges in East Africa from Egypt, south to Kenya \[[@B3-medicines-04-00017]\], and the southern Arabian Peninsula, including Yemen \[[@B4-medicines-04-00017]\], Oman \[[@B5-medicines-04-00017]\], and the United Arab Emirates (UAE) \[[@B6-medicines-04-00017]\]. *O. forskolei* is used traditionally in Yemen as a cosmetic, to relieve fever, and to treat skin infections \[[@B7-medicines-04-00017]\]. In UAE, crushed leaves of *O. forskolei* are used to treat headaches, colds, and ear aches, while the juice is used as eye drops or for insect bites \[[@B6-medicines-04-00017]\]. The plant is used in Eritrea as a mosquito repellent and has demonstrated repellent activity \[[@B8-medicines-04-00017]\]. The dichloromethane extract of *O. forskolei* has shown weak antibacterial activity against Gram-positive bacteria, while the methanol extract showed minimal radical-scavenging activity \[[@B7-medicines-04-00017]\]. Previous investigations of *O. forskolei* have shown the essential oil to have weak antioxidant \[[@B9-medicines-04-00017]\] and nematicidal activity \[[@B10-medicines-04-00017]\], and better activities against bacteria and dermatophytes \[[@B11-medicines-04-00017]\].

*Teucrium* is a large genus belonging to the Lamiaceae which contains about 250 species that are widespread over the world, but are most common in Mediterranean climates \[[@B2-medicines-04-00017]\]. *Teucrium* species endemic to Yemen are *T. yemense* Deflers, *T. socotranum* (Balf. f.) Vierh., and *T. balfourii* (Balf. f.) Vierh. Plants from this genus are perennial in the form of herbs, shrubs, and sub-shrubs. *Teucrium* species are widely used in Yemeni folk medicine as antispasmodics and insect repellants \[[@B12-medicines-04-00017]\]. *Teucrium* species are rich in essential oil and are valued as ornamental plants. *Teucrium yemense* is mostly found in Djibouti, Ethiopia, Saudi Arabia, Sudan, and Yemen. It is a perennial aromatic plant possessing sessile oblanceolate leaves and dense terminal heads of white flowers \[[@B12-medicines-04-00017]\]. Essential oil studies of various species of *Teucrium* have shown α-humulene, δ-cadinene, (*E*)-caryophyllene, α-pinene, β-pinene, linalool, 3-octanol, α-cadinol, caryophyllene oxide, 8-cedren-13-ol, and (*E*)-β-farnesene to be the major components of the essential oils. A wide range of biological activity has been reported for *Teucrium* species, some of which are attributed to the high content of essential oil in them. They possess antifungal, antibacterial, larvicidal, antispasmodic, antioxidant, anti-inflammatory, antiulcer, hypoglycemic, antiacetylcholinesterase, and hepatoprotective activities \[[@B12-medicines-04-00017]\].

2. Materials and Methods {#sec2-medicines-04-00017}
========================

2.1. Plant Materials {#sec2dot1-medicines-04-00017}
--------------------

The leaves of *O. forskolei* and *T. yemense* were collected from several mature plants during the flowering stage in May 2010 from Dhamar province, Yemen. The plants were identified by Hassan M. Ibrahim of the Botany Department, Faculty of Sciences, Sana'a University. Voucher specimens (YMP Lam-33 and YMP Lam-36) have been deposited at the Pharmacognosy Department, Sana'a University, Yemen*.* Another sample of *T. yemense* leaves was collected in February 2012 from Taiz town, Yemen. For each sample, the dried leaves (100 g) were hydrodistilled for 3 h in a Clevenger type apparatus according to the European Pharmacopoeia method \[[@B13-medicines-04-00017]\]. The obtained oils were subsequently dried over anhydrous Na~2~SO~4~ and kept at 4 °C until analysis.

2.2. Gas Chromatography-Mass Spectrometry (GC-MS) {#sec2dot2-medicines-04-00017}
-------------------------------------------------

*O. forskolei* and *T. yemense* essential oils were analyzed by GC-MS using an Agilent 6890 GC with an Agilent 5973 mass selective detector (MSD, operated in the EI mode (electron energy = 70 eV), scan range = 40--400 amu, and scan rate = 3.99 scans/s), and an Agilent ChemStation data system. The GC column was an HP-5ms fused silica capillary with a (5% phenyl)-polymethylsiloxane stationary phase, film thickness of 0.25 μm, a length of 30 m, and an internal diameter of 0.25 mm. The carrier gas was helium with a column head pressure of 48.7 kPa and a flow rate of 1.0 mL/min. Inlet temperature was 200 °C and interface temperature was 280 °C. The GC oven temperature program was used as follows: 40 °C initial temperature, held for 10 min; increased at 3 °C/min to 200 °C; increased 2°/min to 220 °C. A 1% (*w*/*v*) solution of the sample in CH~2~Cl~2~ was prepared and 1 μL was injected using a splitless injection technique. Identification of the oil components was based on their retention indices as determined by reference to a homologous series of *n*-alkanes (C~8~--C~40~), and by comparison of their mass spectral fragmentation patterns with those reported in the literature \[[@B14-medicines-04-00017]\], and stored on the MS library (NIST database (G1036A, revision D.01.00)/ChemStation data system (G1701CA, version C.00.01.080). The percentages of each component are reported as raw percentages based on total ion current without standardization.

2.3. Radical Scavenging Assay {#sec2dot3-medicines-04-00017}
-----------------------------

For the preliminary test, analytical TLC (thin-layer chromatography) on silica gel plates was developed under appropriate conditions after application of 5 μL of oil solution, dried and sprayed with DPPH solution (0.2%, MeOH). Five minutes later, active compounds appeared as yellow spots against a purple background. Estimation of a radical scavenging effect was carried out by using a DPPH (2,2-diphenyl-1-picrylhydrazyl) free radical scavenger assay in 96-well microtiter plates (MTPs) according to a modified method \[[@B15-medicines-04-00017]\]. A solution of DPPH (Sigma-Aldrich, Munich, Germany) was prepared by dissolving 5 mg DPPH in 2 mL of methanol, and the solution was kept in the dark at 4 °C until use. Stock solutions of the samples were prepared at 2 mg/mL and diluted to different concentrations. Methanolic DPPH solution (5 μL) was added to each well. The plate was shaken for 2 min to ensure thorough mixing before being wrapped in aluminum foil and stored in the dark. A methanolic solution of DPPH served as control. After 30 min, the optical density (OD) of the solution was measured at a wavelength of 517 nm using a microtiter plate ELISA reader (Thermo Scientific, Helsinki, Finland) and the percentage decolorization was calculated as an indication of the antioxidant activity of a sample. Each experiment was carried out in triplicate and IC~50~ (median inhibitory concentration) values were calculated using Origin software (version 7, OriginLab Corp., Northampton, MA, USA). Ascorbic acid (Sigma-Aldrich, Munich, Germany) was used as a positive control.

2.4. Antimicrobial Assays {#sec2dot4-medicines-04-00017}
-------------------------

The antimicrobial activities of *O. forskolei* (EOOF) and *T. yemense* (EOTY-d) essential oils were evaluated by the agar disc-diffusion method, as previously described \[[@B16-medicines-04-00017]\]. The microorganisms used were *Escherichia coli* ATCC 10536, *Pseudomonas aeruginosa* ATCC 25619, *Staphylococcus aureus* ATCC 29737, *Bacillus subtilis* ATCC 6633, methicillin-resistant *Staphylococcus aureus* (MRSA), and *Candida albicans* ATCC 2091. Müller-Hinton Agar (MHA) (Merck, Darmstadt, Germany) was used for bacterial culture at 37 °C. Sabouraud dextrose agar (Merck, Darmstadt, Germany) was used to cultivate *C. albicans*.

*T. yemense* (EOTY-t) essential oil was screened for antibacterial activity against the Gram-positive bacteria *Bacillus cereus* (ATCC No. 14579) and *Staphylococcus aureus* (ATCC No. 29213) and the Gram-negative bacteria *Pseudomonas aeruginosa* (ATCC No. 27853) and *Escherichia coli* (ATCC No. 10798). The minimum inhibitory concentrations (MICs) were determined using the microbroth dilution technique \[[@B17-medicines-04-00017]\]. Dilutions of the essential oils were prepared in cation-adjusted Mueller Hinton broth (CAMHB) beginning with 50 µL of 1% *w*/*w* solutions of oils in DMSO plus 50 µL of CAMHB. The oil solutions were serially diluted (1:1) in CAMHB in 96-well plates. Organisms at a concentration of approximately 1.5 × 10^8^ colony-forming units (CFU)/mL were added to each well. Plates were incubated at 37 °C for 24 h, and the final minimum inhibitory concentration (MIC) was determined as the lowest concentration without turbidity. Gentamicin was used as a positive antibiotic control, while DMSO was used as a negative control \[[@B17-medicines-04-00017]\].

The microbroth dilution technique was also applied to determine the antifungal activity of EOTY-t essential oil against *Aspergillus niger* (ATCC No. 16888), *Botrytis cinerea* (ATCC No. 126943), and *Candida albicans* (ATCC No. 90028). For *Aspergillus niger* and *Candida albicans*, dilutions of the essential oils were prepared in YM broth beginning with 50 µL of 1% *w*/*w* solutions of oils in DMSO plus 50 µL of YM broth. The oil solutions were serially diluted (1:1) in YM in 96-well plates. YM broth inoculated with *A. niger* hyphal and *Candida albicans* culture diluted to a McFarland turbidity of 1.0 were added to each well. Plates were incubated at 37 °C for 24 h; amphotericin B was the positive control, while DMSO was used as the negative control. The same process was used for *B. cinerea* as well, except that the inoculum suspension was prepared in potato dextrose broth (PDB) and the inoculum size was adjusted with respective broth medium between 1.0 × 10^6^ and 5.0 × 10^6^ spores/mL by maintaining the optical density (OD) between 0.1 and 0.2 at 625 nm. Dilutions were carried out in the fungal growth medium (malt extract broth). Combination antifungal cyprodinil-fludioxonil was used as the positive control and DMSO was used as the negative control. The 96-well plates were incubated at 25 ± 2 °C for 48 h.

2.5. Cytotoxicity Assays {#sec2dot5-medicines-04-00017}
------------------------

EOOF and EOTY-d were screened for cytotoxicity on HT-29 (human colorectal adenocarcinoma) cells using the XTT assay \[[@B18-medicines-04-00017]\]. HT29 cells were grown in a 5% CO~2~ environment at 37 °C in RPMI 1640 medium without [l]{.smallcaps}-glutamine, supplemented with 10% fetal bovine serum, 1% (200 mM) [l]{.smallcaps}-alanyl-[l]{.smallcaps}-glutamine, and 1.6% HEPES (1 M). Cells were plated into 96-well cell culture plates at 1.5 × 10^3^ cells (HT29) per well. The volume in each well was 100 μL. After 24 h, supernatant fluid was removed by suction and replaced with 100 μL growth medium containing 0.1 μL of a DMSO solution of the essential oil, giving final concentrations of 100, 50, 25, and 12.5 μg/mL for each well. Solutions were added to wells in three replicates. Medium controls without cells and DMSO controls (0.5 μL DMSO/mL) were used. Digitonin (125 µM) was used as a positive control \[[@B19-medicines-04-00017]\]. After the addition of oils, plates were incubated for 72 h at 37 °C in 5% CO~2~; medium was then removed by suction, and 100 μL of fresh medium was added to each well. In order to establish percent growth inhibition rates, the XTT assay for cell viability was carried out according to Cell Proliferation Kit II protocol, (Roche Diagnostics, Mannheim, Germany). After colorimetric readings were recorded (Molecular Devices SpectraMAX M5 microplate reader, 490 nm), average absorbance, growth inhibition, and standard deviations were determined.

EOTY-t was screened for cytotoxic activity against MCF-7 (human breast adenocarcinoma, estrogen receptor positive) and MDA-MB-231 (human breast adenocarcinoma, estrogen receptor negative) cells using MTT-based cytotoxicity assay \[[@B20-medicines-04-00017]\]. Human MCF-7 (ATCC No. HTB-22) and MDA-MB-231 (ATCC No. HTB-26) breast adenocarcinoma cells were grown in a 3% CO~2~ environment at 37 °C in RPMI-1640 medium, supplemented with 10% fetal bovine serum, 100,000 units penicillin, and 10.0 mg streptomycin per liter of medium, 15mM of HEPES, and buffered with 26.7 mM NaHCO~3~, pH 7.35. Cells were plated into 96-well cell culture plates at 2.5 × 10^4^ cells per well. The volume in each well was 100 μL. After 48 h, supernatant fluid was removed by suction and replaced with 100 μL growth medium containing 1.0 μL of DMSO solution of the essential oil (1% *w*/*w* in DMSO), giving a final concentration of 100 μg/mL for each well. Solutions were added to wells in four replicates. Medium controls and DMSO controls (10 μL DMSO/mL) were used. Tingenone was used as a positive control \[[@B21-medicines-04-00017]\]. After the addition of compounds, plates were incubated for 48 h at 37 °C in 5% CO~2~; medium was then removed by suction, and 100 μL of fresh medium was added to each well. In order to establish percent kill rates, the MTT assay for cell viability was carried out \[[@B22-medicines-04-00017]\]. After colorimetric readings were recorded (570 nm, using a SpectraMAX Plus microplate reader, Molecular Devices, Sunnyvale, CA, USA), percent kill was calculated.

3. Results and Discussion {#sec3-medicines-04-00017}
=========================

3.1. Essential Oil Compositions {#sec3dot1-medicines-04-00017}
-------------------------------

### 3.1.1. *Ocimum forskolei* {#sec3dot1dot1-medicines-04-00017}

The chemical composition of the leaf essential oil of *O. forskolei* (EOOF) is listed in [Table 1](#medicines-04-00017-t001){ref-type="table"}. A total of 64 compounds were identified, accounting for 100% of the essential oil composition. The major components were *endo*-fenchol (31.1%), fenchone (12.2%), τ-cadinol (12.2%), and methyl (*E*)-cinnamate (5.1%). The essential oil composition of *O. forskolei* from Yemen is remarkably different from that reported by Fatope and co-workers from Oman \[[@B11-medicines-04-00017]\]. These workers found the leaf oil to be composed largely of estragole (42%--78%) and linalool (10%--16%), but apparently no fenchone, fenchol, methyl cinnamate, or τ-cadinol. Al-Hajj and co-workers collected the essential oil of *O. forskolei* from Sana'a, Yemen, but their essential oil analysis is incorrect and cannot be compared \[[@B9-medicines-04-00017]\]. Headspace analysis of *O. forskolei* from Eritrea showed (*E*)-β-ocimene, 4-hexen-1-yl acetate, 3-hexenol, 1-octen-3-ol, α-copaene, linalool (major), (*E*)-caryophyllene (major), α-humulene, methyl salicylate, and methyl cinnamate \[[@B8-medicines-04-00017]\]. The large discrepancies in essential oil compositions of *O. forskolei* may reflect taxonomic confusion or hybridization \[[@B3-medicines-04-00017],[@B23-medicines-04-00017]\].

### 3.1.2. *Teucrium yemense* {#sec3dot1dot2-medicines-04-00017}

The essential oil compositions of two different collections of *T. yemense* are compiled in [Table 1](#medicines-04-00017-t001){ref-type="table"}. Although there have been several studies on *Teucrium* essential oils, *T. yemense* has not been extensively studied, possibly due to its confined availability. In a previous study, *T. yemense* collected from Taiz (Sabir Mountain, altitude 1300 m) showed a total of 12 identifiable compounds, the major being δ-cadinene (34.9%), (*E*)-caryophyllene (22.7%), α-humulene (6.1%), and α-selinene (5.4%), as well as two unidentified sesquiterpenes (16.5%) \[[@B12-medicines-04-00017]\]. In this current work, two different populations of *T. yemense* were examined, one collected in May 2010 from Dhamar province, and another collected in February, 2012 from Taiz. Although qualitatively similar, there were notable quantitative differences between these two collections and a previous collection from Taiz in 2005 \[[@B12-medicines-04-00017]\]. All three collections showed (*E*)-caryophyllene to be a major component (11.2%--22.7%). δ-Cadinene was the major component from the Taiz sample in 2005 \[[@B12-medicines-04-00017]\], but was only a minor component in the Dhamar sample, while 7-epi-α-selinene (20.1%) and caryophyllene oxide (20.1%) were the major components in the Dhamar sample. α-Humulene was relatively abundant in all three *T. yemense* samples (4.0%--6.4%), while α-cadinol was relatively abundant (2.0 and 9.5%) in the two *T. yemense* samples in this current investigation. Sesquiterpenoids, including (*E*)-caryophyllene, α-humulene, germacrene D, δ-cadinene, caryophyllene oxide, α-cadinol, and τ-cadinol, have been generally abundant in *Teucrium* essential oils ([Table 2](#medicines-04-00017-t002){ref-type="table"}) \[[@B24-medicines-04-00017],[@B25-medicines-04-00017],[@B26-medicines-04-00017],[@B27-medicines-04-00017],[@B28-medicines-04-00017],[@B29-medicines-04-00017],[@B30-medicines-04-00017],[@B31-medicines-04-00017],[@B32-medicines-04-00017],[@B33-medicines-04-00017],[@B34-medicines-04-00017],[@B35-medicines-04-00017],[@B36-medicines-04-00017],[@B37-medicines-04-00017],[@B38-medicines-04-00017],[@B39-medicines-04-00017],[@B40-medicines-04-00017],[@B41-medicines-04-00017],[@B42-medicines-04-00017],[@B43-medicines-04-00017],[@B44-medicines-04-00017],[@B45-medicines-04-00017]\]. Although relatively abundant in *T. yemense*, 7-*epi*-α-selinene has been found in relatively small amounts in *T. persicum* \[[@B46-medicines-04-00017]\] and *T. capitatum* \[[@B33-medicines-04-00017]\].

3.2. Biological Activities {#sec3dot2-medicines-04-00017}
--------------------------

### 3.2.1. Free Radical Scavenging {#sec3dot2dot1-medicines-04-00017}

*O. forskolei* and *T. yemense* leaf oils from Dhamar (2010) were screened for free-radical-inhibitory activity using the DPPH· radical scavenging assay. Neither essential oil showed remarkable radical inhibition (IC~50~ = 31.55 and 31.41 μL/mL, respectively). This is not surprising; neither essential oil has high concentrations of phenolic compounds such a carvacrol, thymol, or eugenol, which are known to be excellent radical scavenging agents \[[@B47-medicines-04-00017]\]. *endo*-Fenchol, the major component in *O. forskolei* oil, (*E*)-caryophyllene and α-humulene, major components in *T. yemense* oil, have shown only weak antioxidant activities \[[@B48-medicines-04-00017]\].

### 3.2.2. Antimicrobial Activity {#sec3dot2dot2-medicines-04-00017}

*O. forskolei* and *T. yemense* essential oils were screened for antibacterial and antifungal activity ([Table 3](#medicines-04-00017-t003){ref-type="table"}). The disc diffusion assay showed *O. forskolei* to have weak antibacterial activity against *Staphylococcus aureus*, but stronger activity against *Bacillus subtilis* with an inhibition zone of 34 mm, and antifungal activity against *Candida albicans* with an inhibition zone of 24 mm. EOTY-d was virtually devoid of antimicrobial activity. Using the broth microdilution assay, EOTY-t showed antibacterial activity against *S. aureus* and *B. cereus* (MIC = 156 μg/mL), as well as antifungal activity against *Aspergillus niger* and *Botrytis cinerea* with MIC of 313 μg/mL.

The antibacterial activity of *O. forskolei* essential oil against *B. subtilis* and *S. aureus* is likely due to methyl (*E*)-cinnamate and τ-cadinol. Methyl cinnamate has shown antibacterial activity against *S. aureus* \[[@B49-medicines-04-00017]\] while τ-cadinol has shown activity against *B. cereus* and *S. aureus* \[[@B50-medicines-04-00017]\]. Apparently neither fenchone nor fenchol are antibacterial \[[@B51-medicines-04-00017]\] and fenchone is also not antifungal \[[@B52-medicines-04-00017]\].

The antibacterial activity of EOTY-t essential oil against *S. aureus*, *B. cereus*, *E. coli*, and *A. niger* can be attributed to the relatively high concentrations of (*E*)-caryophyllene, α-humulene, δ-cadinene, and α-cadinol in the oil. (*E*)-Caryophyllene has shown antibacterial activity against each of these organisms \[[@B53-medicines-04-00017],[@B54-medicines-04-00017]\]. α-Humulene has shown antibacterial activity against *B. cereus* and *S. aureus* \[[@B53-medicines-04-00017]\] as well as antifungal activity against *A. niger* \[[@B53-medicines-04-00017]\]. δ-Cadinene was shown to be antibacterial against *Bacillus subtilis* and *Propionibacterium acnes* \[[@B55-medicines-04-00017],[@B56-medicines-04-00017]\], while α-cadinol has shown activity against *B. cereus* and *S. aureus* \[[@B50-medicines-04-00017]\].

### 3.2.3. Cytotoxic Activity {#sec3dot2dot3-medicines-04-00017}

*O. forskolei* leaf oil was screened for cytotoxic activity against HT-29 human colorectal adenocarcinoma cells, but was inactive ([Table 4](#medicines-04-00017-t004){ref-type="table"}). EOTY-d was active against this cell line with IC~50~ = 43.7 μg/mL. Consistent with this, EOTY-t was active against both MCF-7 and MDA-MB-231 human breast adenocarcinoma cells.

The cytotoxic activities of *T. yemense* leaf essential oils is likely due to the relatively high concentrations of known cytotoxic components such as (*E*)-caryophyllene (MCF-7 \[[@B57-medicines-04-00017]\], HT-29 \[[@B58-medicines-04-00017],[@B59-medicines-04-00017]\], other cell lines \[[@B56-medicines-04-00017]\]) α-humulene (MCF-7 \[[@B57-medicines-04-00017]\], HT-29 \[[@B58-medicines-04-00017],[@B59-medicines-04-00017]\], other cell lines \[[@B60-medicines-04-00017],[@B61-medicines-04-00017]\]) δ-cadinene \[[@B56-medicines-04-00017]\], caryophyllene oxide (MCF-7 \[[@B57-medicines-04-00017]\], other cell lines \[[@B62-medicines-04-00017]\]), and α-cadinol (MCF-7, HT-29 \[[@B63-medicines-04-00017]\], other cell lines \[[@B50-medicines-04-00017]\]). Furthermore, (*E*)-caryophyllene has been shown to potentiate the cytotoxic activities of other sesquiterpenoids \[[@B64-medicines-04-00017]\]. Interestingly, although *O. forskolei* essential oil was not cytotoxic, one of its major components, τ-cadinol, has shown cytotoxic activity \[[@B50-medicines-04-00017]\]. Fenchone, however, has been shown not to be cytotoxic \[[@B57-medicines-04-00017]\], and there are apparently no reports in the literature about cytotoxicity of *endo*-fenchol.

4. Conclusions {#sec4-medicines-04-00017}
==============

In summary, this preliminary phytochemical and bioactivity investigation has described the composition of *Ocimum forskolei* leaf essential oil from Yemen for the first time, and has shown the leaf oil to present moderate antimicrobial properties against *B. subtilis* and *C. albicans*. This activity is consistent with its uses in Yemeni traditional medicine for some skin infections. The variation in the chemical compositions and biological activities of *T. yemense* leaf essential oils can be due to the different environmental factors such as altitude, latitude, or time of collection. Both populations of *T. yemense* showed good cytotoxic activity. There remains the need to follow up this preliminary study and investigate both species more comprehensively in terms of botanical, genetic, phytochemical, and biological properties. This is particularly important because much primary health care in Yemen still relies on traditional herbal practices.
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medicines-04-00017-t001_Table 1

###### 

Leaf essential oil compositions of *Ocimum forskolei* and *Teucrium yemense* from Yemen.

  -------------------------------------------------------------------------------------------------------
  RI~calc~ ^a^   RI~lit~ ^b^   Compound                                 \% Composition            
  -------------- ------------- ---------------------------------------- ---------------- -------- -------
  936            930           α-Thujene                                \-\--            tr ^c^   tr

  942            939           α-Pinene                                 0.5              2.3      6.6

  954            954           Camphene                                 0.3              \-\--    0.1

  959            960           Thuja-2,4(10)-diene                      \-\--            \-\--    tr

  976            975           Sabinene                                 tr               0.5      tr

  979            979           β-Pinene                                 tr               1.1      3.1

  982            979           1-Octen-3-ol                             tr               \-\--    \-\--

  992            990           Myrcene                                  0.4              \-\--    0.2

  1004           1002          α-Phellandrene                           tr               \-\--    \-\--

  1009           1005          (3*Z*)-Hexenyl acetate                   tr               \-\--    \-\--

  1025           1024          *p*-Cymene                               0.1              tr       tr

  1028           1029          Limonene                                 2.5              0.5      1.2

  1031           1031          1,8-Cineole                              0.3              \-\--    \-\--

  1067           1070          *cis*-Sabinene hydrate                   0.3              \-\--    \-\--

  1073           1068          1-Octanol                                tr               \-\--    \-\--

  1088           1086          Fenchone                                 12.2             0.3      \-\--

  1094           1092          6,7-Epoxymyrcene                         0.1              \-\--    \-\--

  1100           1096          Linalool                                 5.7              0.2      0.1

  1113           1116          *endo*-Fenchol                           31.1             0.1      \-\--

  1122           1122          *trans*-Pinene hydrate                   0.1              \-\--    \-\--

  1125           1127          Chrysanthenone                           \-\--            tr       \-\--

  1126           1126          α-Campholenal                            \-\--            tr       0.1

  1137           1140          Nopinone                                 \-\--            tr       \-\--

  1138           1139          *trans*-Pinocarveol                      \-\--            0.4      0.2

  1141           1141          *cis*-Verbenol                           \-\--            tr       0.1

  1144           1144          *trans*-Verbenol                         \-\--            1.0      0.3

  1145           1146          Camphor                                  6.2              \-\--    \-\--

  1157           1159          Sabina ketone                            \-\--            tr       \-\--

  1162           1164          Pinocarvone                              \-\--            \-\--    tr

  1165           1169          Borneol                                  1.0              \-\--    tr

  1167           1169          *p*-Mentha-1,5-dien-8-ol                 \-\--            \-\--    0.1

  1177           1177          Terpinen-4-ol                            0.2              0.2      tr

  1183           1182          *p*-Methylacetophenone                   tr               tr       \-\--

  1185           1182          *p*-Cymen-8-ol                           0.2              0.1      0.1

  1190           1188          α-Terpineol                              0.8              0.1      0.1

  1195           1195          Myrtenal                                 \-\--            0.4      0.2

  1196           1195          Myrtenol                                 \-\--            \-\--    tr

  1198           1196          Estragole (=Methyl chavicol)             0.2              \-\--    \-\--

  1207           1205          Verbenone                                \-\--            0.6      0.2

  1217           1216          *trans*-Carveol                          \-\--            tr       0.1

  1219           1220          *endo*-Fenchyl acetate                   2.8              \-\--    \-\--

  1237           1241          Cuminaldehyde                            \-\--            tr       \-\--

  1241           1243          Carvone                                  \-\--            tr       tr

  1243           1244          Carvacrol methyl ether                   \-\--            \-\--    tr

  1252           1252          Geraniol                                 tr               \-\--    \-\--

  1285           1288          Bornyl acetate                           0.1              0.4      0.3

  1299           1298          *trans*-Pinocarvyl acetate               \-\--            tr       \-\--

  1302           1299          Carvacrol                                tr               \-\--    0.2

  1305           1299          Methyl (*Z*)-cinnamate                   0.9              \-\--    \-\--

  1324           1326          Myrtenyl acetate                         \-\--            1.0      \-\--

  1334           1338          δ-Elemene                                \-\--            \-\--    0.1

  1349           1348          α-Cubebene                               0.1              tr       0.1

  1375           1376          α-Copaene                                0.1              tr       0.6

  1385           1378          Methyl (*E*)-cinnamate                   5.1              tr       \-\--

  1387           1388          β-Bourbonene                             \-\--            0.3      1.0

  1390           1388          β-Cubebene                               0.2              \-\--    0.2

  1393           1390          β-Elemene                                0.3              0.9      0.3

  1406           1403          Methyl eugenol                           tr               \-\--    \-\--

  1408           1408          (*Z*)-Caryophyllene                      \-\--            tr       0.1

  1409           1409          α-Gurjunene                              \-\--            \-\--    0.2

  1416           1412          α-*cis*-Bergamotene                      tr               \-\--    \-\--

  1419           1419          (*E*)-Caryophyllene                      1.1              11.2     19.1

  1429           1432          β-Copaene                                \-\--            \-\--    0.2

  1437           1434          α-*trans*-Bergamotene                    3.1              0.1      tr

  1439           1439          α-Guaiene                                0.4              tr       tr

  1444           1441          Aromadendrene                            \-\--            \-\--    tr

  1454           1454          α-Humulene                               0.2              4.0      6.4

  1459           1456          (*E*)-β-Farnesene                        0.1              0.1      0.1

  1461           1454          Alloaromadendrene                        \-\--            tr       2.2

  1464           1466          *cis*-Muurola-4(14),5-diene              0.5              \-\--    0.1

  1467           1467          Ethyl (*E*)-cinnamate                    \-\--            tr       \-\--

  1474           1479          *trans*-Cadina-1(6),4-diene              \-\--            \-\--    0.2

  1476           1477          γ-Gurjunene                              \-\--            tr       \-\--

  1478           1479          γ-Muurolene                              \-\--            \-\--    0.4

  1482           1485          Germacrene-D                             0.8              0.1      0.4

  1484           1479 ^d^      γ-Selinene                               \-\--            5.5      0.4

  1487           1490          β-Selinene                               1.2              0.3      2.5

  1495           1494          *epi*-Cubebol                            \-\--            \-\--    0.9

  1495           1496          Valencene                                \-\--            3.7      \-\--

  1496           1492          δ-Selinene                               0.8              \-\--    \-\--

  1497           1500          Bicyclogermacrene                        \-\--            \-\--    0.8

  1500           1496          Viridiflorene                            0.1              \-\--    \-\--

  1502           1500          α-Muurolene                              \-\--            tr       1.0

  1506           1509          Germacrene A                             \-\--            \-\--    0.1

  1507           1509          α-Bulnesene                              0.9              \-\--    \-\--

  1510           1505          β-Bisabolene                             \-\--            tr       0.1

  1516           1513          γ-Cadinene                               2.9              \-\--    2.7

  1521           1522          7-*epi*-α-Selinene                       0.1              20.1     1.3

  1523           1522          *trans*-Calamenene                       0.2              \-\--    \-\--

  1525           1523          δ-Cadinene                               0.2              0.4      6.5

  1532           1535          10-*epi*-Cubebol                         0.1              \-\--    \-\--

  1534           1534          *trans*-Cadina-1,4-diene                 \-\--            \-\--    0.1

  1537           1538          α-Cadinene                               tr               \-\--    0.2

  1547           1544          *cis*-Sesquisabinene hydrate             \-\--            3.4      0.9

  1553           \-\--         Unidentified                             \-\--            1.2      \-\--

  1557           1561          *cis*-Muurol-5-en-4α-ol                  0.1              \-\--    \-\--

  1560           1563          (*E*)-Nerolidol                          \-\--            tr       \-\--

  1565           1565          β-Calacorene                             \-\--            tr       \-\--

  1566           \-\--         Unidentified                             \-\--            0.5      \-\--

  1578           1575          Germacrene D-4-ol                        \-\--            \-\--    3.1

  1584           1583          Caryophyllene oxide                      0.2              20.1     4.3

  1604           1602          Ledol                                    \-\--            3.6      0.5

  1610           1608          Humulene epoxide II                      \-\--            \-\--    0.9

  1616           1619          1,10-di-*epi*-Cubenol                    1.6              \-\--    0.1

  1619           1623          10-*epi*-γ-Eudesmol                      \-\--            0.6      0.3

  1629           1628          1-*epi*-Cubenol                          \-\--            0.6      0.6

  1637           1640          Caryophylla-4(12),8(13)-dien-5-ol        \-\--            0.7      0.4

  1643           1640          τ-Cadinol                                12.2             2.0      5.7

  1646           1642          τ-Muurolol                               \-\--            0.6      4.9

  1647           1646          α-Muurolol (= Torreyol)                  \-\--            \-\--    0.7

  1648           1649          Methyl (*Z*)-jasmonate                   0.2              \-\--    \-\--

  1653           1650          β-Eudesmol                               0.1              0.9      0.3

  1657           1654          α-Cadinol                                0.4              2.0      9.5

  1660           1663\         7-*epi*-α-Eudesmol\                      \-\--            3.3      \-\--
                 1666\         + Intermediol\                                                     
                 1661          + *cis*-Calamenen-10-ol                                            

  1668           1669          *trans*-Calamenen-10-ol                  \-\--            0.6      \-\--

  1672           1671          *epi*-β-Bisabolol                        \-\--            \-\--    0.3

  1672           1669          14-Hydroxy-9-*epi*-(*E*)-caryophyllene   \-\--            0.8      \-\--

  1674           1676          Cadalene                                 \-\--            0.4      \-\--

  1685           1685          α-Bisabolol                              0.1              \-\--    \-\--

  1687           1689          *cis*-14-nor-Muurol-5-en-4-one           0.3              \-\--    \-\--

  1690           1689          Shyobunol                                \-\--            \-\--    4.6

  1704           1702          10-Norcalamenen-10-one                   \-\--            0.2      \-\--

  1738           1740          Oplopanone                               \-\--            0.3      tr

  1773           1775          *epi*-Cyclocolorenone                    \-\--            0.8      \-\--

  1803           1806          Nootkatone                               \-\--            0.6      \-\--

                               Total Identified                         100              91.7     98.6
  -------------------------------------------------------------------------------------------------------

^a^ RI~calc~ = Retention Index calculated with respect to a homologous series of *n*-alkanes on an HP-5ms column; ^b^ RI~lit~ = Retention Index from Adams \[[@B14-medicines-04-00017]\]; ^c^ tr = trace (\<0.05%); EOOF = *Ocimum forskolei* Benth.; EOTY-d = *Teucrium yemense* Deflers collected from Dhamar province; EOTY-t = *Teucrium yemense* Deflers collected from Taiz; ^d^ National Institute of Standards and Technology (NIST).

medicines-04-00017-t002_Table 2

###### 

Major sesquiterpenoid components found in *Teucrium* essential oils.

  Major Sesquiterpenoid             *Teucrium* Species              \%                                                                                  Refs.
  --------------------------------- ------------------------------- ----------------------------------------------------------------------------------- -------------------------------
  (*E*)-Caryophyllene               *T. chamaedrys*                 47.6                                                                                \[[@B24-medicines-04-00017]\]
  *T. polium*                       52.0                            \[[@B24-medicines-04-00017]\]                                                       
  *T. arduini*                      35.2                            \[[@B25-medicines-04-00017]\]                                                       
  *T. turredanum*                   15.6--32.6                      \[[@B26-medicines-04-00017]\]                                                       
  *T. scorodonia* ssp. *baeticum*   33.8                            \[[@B27-medicines-04-00017]\]                                                       
  α-Humulene                        *T. alopecurus*                 12.3                                                                                \[[@B28-medicines-04-00017]\]
  *T. flavum*                       8.4                             \[[@B29-medicines-04-00017]\]                                                       
  *T. marum*                        7.2                             \[[@B30-medicines-04-00017]\]                                                       
  *T. polium*                       4.3                             \[[@B31-medicines-04-00017]\]                                                       
  *T. scorodonia* ssp. *baeticum*   9.1                             \[[@B27-medicines-04-00017]\]                                                       
  *T. turredanum*                   4.7--10.1                       \[[@B26-medicines-04-00017]\]                                                       
  Germacrene D ^a^                  *T. sandrasicum*                27.9                                                                                \[[@B42-medicines-04-00017]\]
  *T. arduini*                      17.0--18.7                      \[[@B25-medicines-04-00017],[@B43-medicines-04-00017]\]                             
  *T. chamaedrys*                   16.5--32.1                      \[[@B24-medicines-04-00017],[@B44-medicines-04-00017],[@B45-medicines-04-00017]\]   
  *T. scorodonia* ssp. *baeticum*   22.2                            \[[@B27-medicines-04-00017]\]                                                       
  δ-Cadinene                        *T. montanum*                   17.2                                                                                \[[@B32-medicines-04-00017]\]
  *T. capitatum*                    3.0--9.8                        \[[@B33-medicines-04-00017]\]                                                       
  *T. maghrebinum*                  13.5                            \[[@B34-medicines-04-00017]\]                                                       
  *T. ramosissimum*                 20.0                            \[[@B35-medicines-04-00017]\]                                                       
  *T. stocksianum*                  12.9                            \[[@B36-medicines-04-00017]\]                                                       
  Caryophyllene oxide               *T. orientale* ssp. *taylori*   15.6                                                                                \[[@B37-medicines-04-00017]\]
  *T. montbretti*                   12.7                            \[[@B38-medicines-04-00017]\]                                                       
  *T. arduini*                      14.6                            \[[@B39-medicines-04-00017]\]                                                       
  α-Cadinol                         *T. polium* ssp. *aurasiacum*   46.8                                                                                \[[@B40-medicines-04-00017]\]
  *T. polium* ssp. *capitatum*      4.5                             \[[@B38-medicines-04-00017]\]                                                       
  *T. ramosissimum*                 9.9                             \[[@B35-medicines-04-00017]\]                                                       
  *T. leucocladum*                  9.3                             \[[@B41-medicines-04-00017]\]                                                       
  *T. capitatum*                    1.6--9.8                        \[[@B33-medicines-04-00017]\]                                                       
  τ-Cadinol                         *T. capitatum*                  1.6--24.1                                                                           \[[@B33-medicines-04-00017]\]
  *T. montanum*                     5.5                             \[[@B42-medicines-04-00017]\]                                                       
  *T. leucocladum*                  5.5                             \[[@B41-medicines-04-00017]\]                                                       

^a^ Not abundant in *T. yemense* essential oils.

medicines-04-00017-t003_Table 3

###### 

Antimicrobial activity (minimum inhibitory concentration (MIC), μg/mL) of *Ocimum forskolei* and *Teucrium yemense* leaf essential oils.

  Organism          EOOF ^a^   EOTY-t ^b^   Positive Control
  ----------------- ---------- ------------ ------------------
  *S. aureus*       4300       156          0.61 ^e^
  MRSA              8600       nt ^c^       \<10.0 ^f^
  *B. cereus*       nt         156          1.22 ^e^
  *B. subtilis*     4300       nt           \<10.0 ^e^
  *E. coli*         na ^d^     313          1.22 ^e^
  *P. aeruginosa*   na         1250         2.44 ^e^
  *C. albicans*     8600       1250         0.61 ^g^
  *A. niger*        nt         313          0.61 ^g^
  *B. cinerea*      nt         313          \<19.5 ^g^

^a^ Antimicrobial activity of *O. forskolei* essential oil determined using the disc diffusion assay; ^b^ Antimicrobial activity determined using the broth dilution assay on *T. yemense* Taiz (2012) essential oil; ^c^ "nt" = not tested; ^d^ "na" = not active (no zone of inhibition); ^e^ Bacterial positive control, gentamicin sulfate; ^f^ MRSA positive control, enoxacin; ^g^ Fungal positive control, amphotericin B.

medicines-04-00017-t004_Table 4

###### 

Cytotoxic activity (IC~50~, μg/mL) of *Ocimum forskolei* and *Teucrium yemense* leaf essential oils.

  Cell Line    EOOF     EOTY-d       EOTY-t
  ------------ -------- ------------ ------------
  HT-29        na ^a^   43.7 ± 7.1   nt ^b^
  MCF-7        nt       nt           24.4 ± 1.8
  MDA-MB-231   nt       nt           59.9 ± 4.6

^a^ "na" = not active (0% kill at 100 μg/mL); ^b^ "nt" = not tested.
